Blood Cancer, Cancer, Multiple Myeloma |
Somatic Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCSF |
|
Development Candidate, Proof of Concept |
|
Neurological Disorders, Spinal Cord Injury |
iPS Cell |
Other Components, Personalized cell therapy, Therapeutic Approach |
Stanford |
|
Development Candidate, Proof of Concept |
|
Heart Disease, Heart failure |
Adult or Tissue Stem Cell |
Biologic, Nucleic acid based therapy, Therapeutic Approach |
Cedars-Sinai |
|
Development Candidate, Proof of Concept |
|
Neurological Disorders |
iPS Cell |
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
Navega Therapeutics |
|
Development Candidate, Proof of Concept |
|
Heart Disease |
iPS Cell |
Model system development, Specific Cell Type Derivation, Technology |
Stanford |
|
Development Candidate, Proof of Concept |
|
Amyotrophic Lateral Sclerosis, Neurological Disorders |
Adult or Tissue Stem Cell |
Donor cell therapy, Small molecule therapy, Therapeutic Approach |
UCSD |
|
Development Candidate, Proof of Concept |
|
Epidermolysis Bullosa, Skin Disease |
iPS Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
Stanford |
|
Development Candidate, Proof of Concept |
|
Cancer, Ovarian Cancer, Solid Tumors |
iPS Cell |
Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach |
UCSD |
|
Development Candidate, Proof of Concept |
|
Angelman Syndrome, Autism, Neurological Disorders |
iPS Cell |
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
UC Davis |
|
Development Candidate, Proof of Concept |
|
Heart Disease, Heart failure |
iPS Cell |
Biologic, Exosomes based therapy, Nucleic acid based therapy, Therapeutic Approach |
Stanford |
|
Development Candidate, Proof of Concept |
|
Anemia, Blood Disorders |
Adult or Tissue Stem Cell, iPS Cell |
Small molecule therapy, Therapeutic Approach |
Stanford |
|
Development Candidate, Proof of Concept |
|
Liver Disease, Metabolic Disorders |
iPS Cell |
Diagnostic Test, Technology |
UCSF |
|
Development Candidate, Proof of Concept |
|
Brain Cancer, Cancer, Neurological Disorders, Solid Tumors |
Embryonic Stem Cell |
Biologic, Exosomes based therapy, Therapeutic Approach |
UC Irvine |
|
Development Candidate, Proof of Concept |
|
Heart Disease |
iPS Cell |
Donor cell therapy, Therapeutic Approach |
UC Davis |
|
Development Candidate, Proof of Concept |
|
Cancer, Pancreatic Cancer, Solid Tumors |
Cancer Stem Cell |
Small molecule therapy, Therapeutic Approach |
UCSD |
|
Development Candidate, Proof of Concept |
|
Liver Disease, Metabolic Disorders |
iPS Cell |
Donor cell therapy, Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach |
CHLA |
|
Development Candidate, Proof of Concept |
|
Other, Toxicity |
iPS Cell |
Model system development, Technology |
Greenstone Biosciences |
|
Tool/Resources/Bottleneck |
|
Heart Disease |
iPS Cell |
Model system development, Technology |
Organos, Inc. |
|
Tool/Resources/Bottleneck |
|
Kidney Disease, Kidney Failure |
Adult or Tissue Stem Cell |
Device, Technology, Therapeutic Approach, Tissue engineering |
UC Davis |
|
Pre-IND/IDE or Equivalent |
|
Beta Thalassemia, Blood Disorders, Sickle Cell Disease |
Adult or Tissue Stem Cell |
Diagnostic Test, Technology |
UCSF |
|
Regulated Lab Test, Ready for Validation |
|
Blood Cancer, Cancer, Multiple Myeloma |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach |
COH |
|
Pre-IND/IDE or Equivalent |
|
Corneal Damage, Vision Loss |
|
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Blood Disorders |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
ImmunoVec |
|
Pre-IND/IDE or Equivalent |
|
Corneal Damage, Vision Loss |
Adult or Tissue Stem Cell |
Biologic, Exosomes based therapy, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Neurological Disorders, Parkinson's Disease |
iPS Cell |
Personalized cell therapy, Therapeutic Approach |
BrainXell Therapeutics |
|
Pre-IND/IDE or Equivalent |
|
HIV/AIDS, Infectious Disease |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Lung Disease, Fibrosis, Respiratory Disorders |
|
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
Rejuvenation Technologies, Inc. |
|
Pre-IND/IDE or Equivalent |
|
Diabetes, Metabolic Disorders |
|
Donor cell therapy, Therapeutic Approach |
Stanford |
|
Pre-IND/IDE or Equivalent |
|
Cancer, Lung Cancer, Solid Tumors |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
USC |
|
Pre-IND/IDE or Equivalent |
|
Infectious Disease |
|
Biologic, Nucleic acid based therapy, Therapeutic Approach |
VxBiosciences inc. |
|
Pre-IND/IDE or Equivalent |
|
Breast Cancer, Cancer, Solid Tumors |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach |
COH |
|
Pre-IND/IDE or Equivalent |
|
B cell cancers, Blood Cancer, Cancer |
|
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UC Davis |
|
Pre-IND/IDE or Equivalent |
|
Neurological Disorders, Pediatrics |
|
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
Mahzi Therapeutics |
|
Pre-IND/IDE or Equivalent |
|
Neurological Disorders, Other |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCSD |
|
Pre-IND/IDE or Equivalent |
|
Cancer, Prostate Cancer, Solid Tumors |
|
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
USC |
|
Pre-IND/IDE or Equivalent |
|
Retinitis Pigmentosa, Vision Loss |
Somatic Cell |
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
Ray Therapeutics, INC |
|
Pre-IND/IDE or Equivalent |
|
Heart Disease, Hypertension, pulmonary arterial, Pulmonary Hypertension |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Neurological Disorders, Spinal Cord Injury |
Adult or Tissue Stem Cell |
Donor cell therapy, Therapeutic Approach |
UC Irvine |
|
Pre-IND/IDE or Equivalent |
|
B cell cancers, Blood Cancer, Cancer |
Somatic Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCSF |
|
Pre-IND/IDE or Equivalent |
|
Duchenne Muscular Dystrophy, Skeletal/Smooth Muscle disorders |
Somatic Cell |
Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach |
MyoGene Bio LLC |
|
Pre-IND/IDE or Equivalent |
|
Heart Disease |
iPS Cell |
Biologic, Protein/peptide therapy, Therapeutic Approach |
Regencor, Inc. |
|
Pre-IND/IDE or Equivalent |
|
Genetic Disorder, Metabolic Disorders |
Somatic Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
Immusoft Corporation |
|
Pre-IND/IDE or Equivalent |
|
Brain Cancer, Cancer, Solid Tumors |
Somatic Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCSF |
|
Pre-IND/IDE or Equivalent |
|
Blood Disorders, IPEX Syndrome |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
ImmunoVec |
|
Pre-IND/IDE or Equivalent |
|
Heart Disease |
Adult or Tissue Stem Cell |
Antibody, Biologic, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Neurological Disorders, Stroke |
iPS Cell |
Donor cell therapy, Therapeutic Approach |
PAVIR |
|
Pre-IND/IDE or Equivalent |
|
Muscular Dystrophy, Skeletal/Smooth Muscle disorders |
|
Biologic, Protein/peptide therapy, Therapeutic Approach |
Juvena Therapeutics Inc. |
|
Pre-IND/IDE or Equivalent |
|
Neurological Disorders, Stroke |
iPS Cell |
Donor cell therapy, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Cancer, Melanoma, Solid Tumors |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|
Blood Cancer, Cancer, Multiple Myeloma |
Adult or Tissue Stem Cell |
Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach |
UCLA |
|
Pre-IND/IDE or Equivalent |
|